Clinical Trial

Immune Health Biomarkers and Fecal Microbiota in Filipino Breastfed Infants

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This will be a prospective observational study aiming to investigate immune health biomarkers and fecal microbiota in 48-60 Filipino breastfed infants from birth to 12 months of age. An optional follow-up period of approximately 2 years will follow.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-11-25; most recent amendment 2026-04-02.
Status change: Recruiting → Active, Not Recruiting 2025-02-19
Status change: Not Yet Recruiting → Recruiting 2024-12-05
Trial Details
NCT Number NCT06708559
Lead Sponsor Société des Produits Nestlé (SPN)
Collaborators: Asian Hospital and Medical Center, Muntinlupa City, Philippines
Conditions Healthy
Enrollment 60 participants
Start Date 2024-11-29
Primary Completion 2026-01-30 (estimated)
Study Completion 2026-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-03